diversification.com

SNPX

Companies
NASDAQ
Synaptogenix Inc.
Health Care
OverviewNewsRisk & CorrelationForecasts
Price Chart
Overview

About SNPX

synaptogenix is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases.

Market Cap
$5.1M
Volume
37.8K
Avg. Volume
30.3K
P/E Ratio
-0.23477753
Dividend Yield
0.00%
Employees
5.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Latest News for SNPX

5 Health Care Stocks That Are Diving - And May Rally

January 19, 2023
Risk & Correlation Analysis
Market Correlation
0.69
Low Correlation
Volatility
High (0.82)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for SNPX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, SNPX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$5.1M
Volume37.8K
P/E Ratio-0.23
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 21, 2023
Related Securities
SAGE
Sage Therapeutics Inc.
ALDX
Aldeyra Therapeutics Inc.

PortfolioPilot Analysis

Get AI-powered insights on how SNPX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025